MRC1 and gastric cancer: In gastric cancer, deficient MMR (dMMR) and MSI are observed in approximately 15–30% of cases, whereas in pancreatic cancer, MMR gene mutations and MSI are less common, with a prevalence of 1–2% [69,70,71].